BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16385491)

  • 41. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. mAbs in nonlupus autoimmune rheumatic disease.
    Whelan BR; Isenberg DA
    Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1(st) French-Israeli International Conference on B Cells and therapeutic antibodies: October 23-25, 2011 Jerusalem, Israel.
    Reynaud CA; Moutel S; Dieu-Nosjean MC; Laskov R; Teillaud JL
    MAbs; 2012; 4(4):426-33. PubMed ID: 22664457
    [No Abstract]   [Full Text] [Related]  

  • 44. Trends in the development of therapeutic anti-cytokine antibodies.
    Reichert JM
    Drug Discov Today; 2004 Apr; 9(8):348. PubMed ID: 15081960
    [No Abstract]   [Full Text] [Related]  

  • 45. Photopheresis in the treatment of autoimmune disease: experience with pemphigus vulgaris and systemic sclerosis.
    Rook AH
    Ann N Y Acad Sci; 1991 Dec; 636():209-16. PubMed ID: 1793210
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferons and scleroderma-a new clue to understanding the pathogenesis of scleroderma?
    Coelho LF; de Oliveira JG; Kroon EG
    Immunol Lett; 2008 Jun; 118(2):110-5. PubMed ID: 18499269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination with cytokines in autoimmune diseases.
    Delavallée L; Assier E; Denys A; Falgarone G; Zagury JF; Muller S; Bessis N; Boissier MC
    Ann Med; 2008; 40(5):343-51. PubMed ID: 18484346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rituximab treatment in children: comment on the review by Looney et al.
    Bader-Meunier B
    Arthritis Rheum; 2008 Aug; 58(8):2583; author reply 2583-4. PubMed ID: 18668567
    [No Abstract]   [Full Text] [Related]  

  • 50. Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis.
    Sakkas LI; Chikanza IC; Platsoucas CD
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):679-85. PubMed ID: 17133253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B cells as therapeutic targets in autoimmune neurological disorders.
    Dalakas MC
    Nat Clin Pract Neurol; 2008 Oct; 4(10):557-67. PubMed ID: 18813230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen's effects in chronic autoimmune/inflammatory diseases and progression to cancer.
    Cutolo M; Sulli A; Straub RH
    Expert Rev Clin Immunol; 2014 Jan; 10(1):31-9. PubMed ID: 24308839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B(effector)reaking bad in systemic sclerosis: role of a novel B cell subset.
    O'Reilly S; van Laar J
    Clin Exp Immunol; 2020 Sep; 201(3):231-232. PubMed ID: 32783250
    [No Abstract]   [Full Text] [Related]  

  • 54. The Autoimmune Tautology with a Focus on Systemic Sclerosis.
    Anaya JM
    Isr Med Assoc J; 2017 Mar; 19(3):186-187. PubMed ID: 28457099
    [No Abstract]   [Full Text] [Related]  

  • 55. Inflammation and immune diseases: what is at the summit?
    Cushley W
    Drug Discov Today; 2005 Jun; 10(11):752-4. PubMed ID: 15922932
    [No Abstract]   [Full Text] [Related]  

  • 56. Biologics in autoimmune diseases.
    Shi G; Liu Y
    Curr Pharm Biotechnol; 2014; 15(6):509. PubMed ID: 25213358
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical implications of basic science discoveries: janus resurrected--two faces of B cell and plasma cell biology.
    Woodle ES; Rothstein DM
    Am J Transplant; 2015 Jan; 15(1):39-43. PubMed ID: 25382283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective antibodies against HSP60 for autoimmune inflammatory diseases.
    Ulmansky R; Naparstek Y
    Clin Immunol; 2018 Jan; 186():63. PubMed ID: 28751270
    [No Abstract]   [Full Text] [Related]  

  • 59. Understanding the pathogenesis and developing new therapy of systemic sclerosis.
    Sato S
    J Dermatol; 2016 Jan; 43(1):9. PubMed ID: 26782001
    [No Abstract]   [Full Text] [Related]  

  • 60. Scleroderma: immunopathogenesis and treatment.
    Rose NR; Leskovsek N
    Immunol Today; 1998 Nov; 19(11):499-501. PubMed ID: 9818542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.